These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 23226520)
21. Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiency. Tuckett AZ; Thornton RH; O'Reilly RJ; van den Brink MRM; Zakrzewski JL J Hematol Oncol; 2017 May; 10(1):109. PubMed ID: 28511686 [TBL] [Abstract][Full Text] [Related]
23. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice. Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956 [TBL] [Abstract][Full Text] [Related]
24. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Ito M; Hiramatsu H; Kobayashi K; Suzue K; Kawahata M; Hioki K; Ueyama Y; Koyanagi Y; Sugamura K; Tsuji K; Heike T; Nakahata T Blood; 2002 Nov; 100(9):3175-82. PubMed ID: 12384415 [TBL] [Abstract][Full Text] [Related]
25. Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID mice. Nitsche A; Junghahn I; Thulke S; Aumann J; Radonić A; Fichtner I; Siegert W Stem Cells; 2003; 21(2):236-44. PubMed ID: 12634420 [TBL] [Abstract][Full Text] [Related]
26. Hematopoietic engraftment of XLA bone marrow CD34(+) cells in NOG/SCID mice. Moreau T; Bardin F; Barlogis V; Le Deist F; Chabannon C; Tonnelle C Cytotherapy; 2009; 11(2):198-205. PubMed ID: 19235603 [TBL] [Abstract][Full Text] [Related]
27. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells. Ito R; Katano I; Ida-Tanaka M; Kamisako T; Kawai K; Suemizu H; Aiso S; Ito M J Immunol; 2012 Nov; 189(9):4313-20. PubMed ID: 23018460 [TBL] [Abstract][Full Text] [Related]
28. Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) mice. Robinson SN; Simmons PJ; Thomas MW; Brouard N; Javni JA; Trilok S; Shim JS; Yang H; Steiner D; Decker WK; Xing D; Shultz LD; Savoldo B; Dotti G; Bollard CM; Miller L; Champlin RE; Shpall EJ; Zweidler-McKay PA Exp Hematol; 2012 Jun; 40(6):445-56. PubMed ID: 22306295 [TBL] [Abstract][Full Text] [Related]
29. An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rγnull mice allows HIV replication and development of anti-HIV immune responses. Singh M; Singh P; Gaudray G; Musumeci L; Thielen C; Vaira D; Vandergeeten C; Delacroix L; Van Gulck E; Vanham G; de Leval L; Rahmouni S; Moutschen M PLoS One; 2012; 7(6):e38491. PubMed ID: 22675567 [TBL] [Abstract][Full Text] [Related]
30. Data on long-term survival of the NOD/Shi-scid IL-2Rγ Yamashita Y; Sato T; Noishiki K; Kobayashi K; Uchiyama A; Izumi H; Tamura T; Shikamura M; Oinishi Y; Saito M; Kawamata S J Toxicol Sci; 2021; 46(10):453-469. PubMed ID: 34602530 [TBL] [Abstract][Full Text] [Related]
31. Comparison of human cord blood engraftment between immunocompromised mouse strains. McDermott SP; Eppert K; Lechman ER; Doedens M; Dick JE Blood; 2010 Jul; 116(2):193-200. PubMed ID: 20404133 [TBL] [Abstract][Full Text] [Related]
32. The Preconditioning of Busulfan Promotes Efficiency of Human CD133+ Cells Engraftment in NOD Shi-SCID IL2Rγcnull (NOG) Mice via Intra-Bone Marrow Injection. Guo X; Yin X; Zhu W; Pan Y; Wang H; Liang Y; Zhu X Cell Transplant; 2019 Jul; 28(7):973-979. PubMed ID: 30983406 [TBL] [Abstract][Full Text] [Related]
33. Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null) (NOG) mice. Takajo I; Umeki K; Morishita K; Yamamoto I; Kubuki Y; Hatakeyama K; Kataoka H; Okayama A Int J Cancer; 2007 Nov; 121(10):2205-11. PubMed ID: 17657714 [TBL] [Abstract][Full Text] [Related]
34. An in vivo model of priming of antigen-specific human CTL by Mo-DC in NOD/Shi-scid IL2rgamma(null) (NOG) mice. Inoue M; Senju S; Hirata S; Irie A; Baba H; Nishimura Y Immunol Lett; 2009 Sep; 126(1-2):67-72. PubMed ID: 19682495 [TBL] [Abstract][Full Text] [Related]
35. Benzene-Induced Aberrant miRNA Expression Profile in Hematopoietic Progenitor Cells in C57BL/6 Mice. Wei H; Zhang J; Tan K; Sun R; Yin L; Pu Y Int J Mol Sci; 2015 Nov; 16(11):27058-71. PubMed ID: 26569237 [TBL] [Abstract][Full Text] [Related]
36. Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice. Tomita H; Fuchimoto Y; Mori T; Kato J; Uemura T; Handa M; Tazawa H; Ohdan H; Okamoto S; Kuroda T Clin Transplant; 2013; 27(6):E702-8. PubMed ID: 24125194 [TBL] [Abstract][Full Text] [Related]
37. Long-term maintenance of peripheral blood derived human NK cells in a novel human IL-15- transgenic NOG mouse. Katano I; Nishime C; Ito R; Kamisako T; Mizusawa T; Ka Y; Ogura T; Suemizu H; Kawakami Y; Ito M; Takahashi T Sci Rep; 2017 Dec; 7(1):17230. PubMed ID: 29222435 [TBL] [Abstract][Full Text] [Related]
38. Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells. McIntosh BE; Brown ME; Duffin BM; Maufort JP; Vereide DT; Slukvin II; Thomson JA Stem Cell Reports; 2015 Feb; 4(2):171-80. PubMed ID: 25601207 [TBL] [Abstract][Full Text] [Related]
39. Enhanced Antibody Responses in a Novel NOG Transgenic Mouse with Restored Lymph Node Organogenesis. Takahashi T; Katano I; Ito R; Goto M; Abe H; Mizuno S; Kawai K; Sugiyama F; Ito M Front Immunol; 2017; 8():2017. PubMed ID: 29387068 [TBL] [Abstract][Full Text] [Related]
40. Conditions that enable human hematopoietic stem cell engraftment in all NOD-SCID mice. Rice AM; Wood JA; Milross CG; Collins CJ; McCarthy NF; Vowels MR Transplantation; 2000 Mar; 69(5):927-35. PubMed ID: 10755552 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]